Hypertension in obstructive sleep apnoea

Vascular Disease Prevention

Volumn 2, Issue 1, 2005, Pages 29-35

  Del Colle, Sara ^a   Carra, Renata ^a   Rabbia, Franco ^a   Papotti, Grazia ^a   Verhovez, Andrea ^a   Mulatero, Paolo ^a   Veglio, Franco ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Autonomic control; Cardiovascular risk; CPAP therapy; Hypertension; Obesity; Obstructive sleep apnoea; Sympathetic activation

Indexed keywords

LEPTIN;

ADRENERGIC STIMULATION; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENDOTHELIUM; GOOD CLINICAL PRACTICE; HEART RATE; HUMAN; HYPERTENSION; HYPOXIA; INCIDENCE; OBESITY; PATHOPHYSIOLOGY; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SLEEP APNEA SYNDROME; VASOCONSTRICTION; WEIGHT REDUCTION;

EID: 20144376084     PISSN: 15672700     EISSN: None     Source Type: Journal    
DOI: 10.2174/1567270052774412     Document Type: Review

References (59)

1. Strollo PJ, Rogers RM. Obstructive sleep apnoea. N Engl J Med 1996, 334: 99-104.
2. He J, Kryger MH, Zorick FJ, Conway W, Roth T. Mortality and apnea index in obstructive sleep apnoea. Experience in 385 male patients. Chest 1988, 94: 9-14.
3. Yamashiro Y, Kryger M. Why should sleep apnoea be diagnosed and treated? Clin Pulm Med 1994, 1: 250-9.
4. Flemons WW. Obstructive sleep apnea. N Engl J Med, Aug 15,2002(347), 7: 498-504.
5. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993, 328: 1230-5.
6. Silverberg DS, Oksenberg A. Are sleep-related breathing disorders important contributing factors to the production of essential hypertension? Curr Hypertens Rep 2001, 3: 209-215.
7. Logan AG, Perlikowski SM, Mente A et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 2001, 19: 2271-77.
8. Maekawa M, Shiomi T, Usui K, Sasanabe R, Kobayashi T. Prevalence of ischemic heart disease among patients with sleep apnoea syndrome. Psychiatry Clin Neursci 1998, 52: 219-20.
9. Roux F, D'Ambrosio C, Mohesenin V. Sleep-related breathing disorders and cardiovascular disease. Am J Med 2000, 108: 396-402.
10. Valencia-Flores M, Orea A, Castano VA et al. Prevalence of sleep apnea and electrocardiographic disturbances in morbidly obese patients. Obes Res 2000; 8: 262-9.
11. Worsnop CJ, Naughton MT, Barter CE, Morgan TO, Anderson AI, Pierce RJ. The prevalence of obstructive sleep apnea in hypertensives. Am J Respir Crit Care Med 1998, 157: 111-115.
12. Young T, Peppard P, Palta M et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 1997, 157: 1746-1756.
13. Nieto FJ, Young TB, Lind BK et al. Association of sleep-disordered breathing, sleep apnoea, and hypertension in large community-based study. Sleep Heath Health Study JAMA 2000, 283: 1829-1836.
14. Modan M, Almog S, Fuchs Z, Chetrit A, Lusky A, Halkin H. Obesity, glucose intolerance, hyperinsulinemia and response to antihypertensive drugs. Hypertension 1991, 17: 565-573.
15. Rajala R, Partinen M, Sane T, Pelkonen R, Huikuri K, Seppalainen AM. Obstructive sleep apnea syndrome in morbidly obese patients. J Intern Med 1991, 230: 125-129.
16. Kiselak J, Clark M, Pera V, Rosemberg C, Redline S. The association between hypertension and sleep apnoea in obese patients. Chest 1993, 104: 775-780.
17. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000, 320: 479-482.
18. Peppard P, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000, 342: 1378-1384.
19. Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnoea - A 7-year follow up. Am J Respir Crit Care Med 2002, 166: 159-165.
20. Vidt DG. In: Oparil-Weber, Hypertension. Philadelphia, WB Saunders Co.2000, 564-571.
21. Levinson PD, Millman RP. Causes and consequences of blood pressure alterations in obstructive sleep apnoea. Arch Intern Med 1991 Mar; 151(3): 455-62.
22. Schroeder JS, Motta J, Guilleminault C. Sleep Apnea Syndromes. New York: Liss, 1978.
23. Bradley G, Somers V. Hypertension and Obstructive sleep apnea. Curr Hypertens Rep 2003, 5: 380-85.
24. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnoea. J Clin Invest 1995, 96: 1897-1904.
25. Narkiewicz K, Pesek CA, Kato M, Phillips ME, Montano N, Somers VK. Baroreflex control of sympathetic nerve activity and heart rate in obstructive sleep apnoea. Hypertension 1998, 32: 1039-1043.
26. Shimizu K, Chin K, Nakamura T et al. Plpsma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome. Thorax 2002 May; 57(5): 429-34.
27. Hedner JA, Wilcox I, Laks L, Grunstein RR, Sullivan CE. A specific and potent pressor effect of hypoxia in patients with sleep apnoea. Am Rev Respir Dis 1992, 146: 1240-1245.
28. Carlson JT, Hedner J, Elam M, Ejnell H, Sellgren J, Wallin BG. Augmented resting sympathetic activity in awake patients with obstructive sleep apnoea. Chest 1993, 103: 1763-1768.
29. Narkiewicz K, van de Borne PJ, Pesek CA et al. Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnoea. Circulation 1999, 99: 1183-1189.
30. Kanagy NL, Walker BR, Nelin LD. Role of endothelin in intermittent hypoxia-induced hypertension. Hypertension 2001, 37: 511-515.
31. Schulz R, Schmidt D, Blum A et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax 2000, 55: 1046-1051.
32. Ip MS, Lam B, Chan LY et al. Circulating nitric oxide is suppressed in obstructive sleep apnoea and is reversed by nasal continuous posivite airways pressure. Am J Respir Crit Care Med 2000, 162: 2166-2171.
33. Barton CH, Ni Z, Vaziri ND. Blood pressure response to hypoxia: role of NO synthase. Am J Hypertens 2003, 16(12): 1043-48.
34. Poirier B, Lannaud-Bournoville M, Conti M et al. Oxidative stress occurs in absence of hyperglycaemia and inflammation in the onset of kidney lesions in normotensive obese rats. Neprhol Dial Transplant 2000, 15: 467-76.
35. Dobrian AD, Davies MJ, Schriver SD, Lauterio TJ, Prewitt RL. Oxidative stress in a rat model of obesity-induced hypertension. Hypertension 2001, 37: 554-60.
36. Schulz R, Mahmoudi S, Hattar K et al. Enhanced release of Superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 2000, 162: 566-70.
37. Djugovskaya L, Lavie P, Lavie L. Increased Adhesion Molecules Expression and Production of Reactive Oxygen Species in Leukocytes of Sleep Apnea Patients. Am J Respir Crit Care Med 2002, 165: 934-39.
38. Vgontzas AN, Tan TL, Bixler EO, Martin LF, Shubert D, Kales A. sleep apnea and sleep disruption in obese patients. Arch Intern Med 1994, 154: 1705-11.
39. Phillips BG, Hisel TM, Kato M et al. Recent weight gain in patients with newly diagnosed obstructive sleep apnoea. J Hypertens 1999, 17: 1297-1300.
40. Phillips BG, Kato M, Narkiewicz K, Choe L, Somers VK. Increased in leptin levels, sympathetic drive and weight gain in obstructive sleep apnoea. Am J Physiol Heart Circ Physiol 2000, 279: H234-H237.
41. Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial arterial pressure. Hypertension 1998, 31: 409-14.
42. Haynes WG, Morgan DA, Walsh SA. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997, 100: 270-78.
43. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002, 165: 670-76.
44. Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002, 165: 677-82.
45. Grote L, Heitmann J, Kohler U, Ploch T, Penzel T, Peter JH. Effect of angiotensin converting enzyme inhibition (cilazapril) on blood pressure recording in hypertensive obstructive sleep apneic patients. Blood Press 1997, 6(4): 235-241.
46. Mayer J, Weichler U, Herres-Mayer B, Schneider H, Marx U, Peter JH. Influence of metoprolol and cilazapril on blood pressure and on sleep apnoea activity. J Cardiovasc Pharmacol 1990, 16(6): 952-61.
47. Planes C, Foucher A, Leroy M et al. Effect of celiprolol treatment in hypertensive patients with sleep apnea. Sleep 1999, 15; 22(4): 507-513.
48. Becker HF, Jerrentrup A, Ploch T et al. Effect of nasal continuous positive airways pressure treatment on blood pressure in patients with obstructive sleep apnoea. Circulation 2003, 107: 68-73.
49. Logan AG, Tkacova R, Perlikowski SH et al. Refractory hypertension and sleep apnea: effect of CPAP on blood pressure and baroreflex. Eur Respir J 2003, 21: 241-47.
50. Dimsdale JE, Loredo JS, Profant J. Effect of continuous positive airway pressure on blood pressure: a placebo trial. Hypertension 2000, 35: 144-147.
51. Engleman HM, Gough K, Martin SE, Kingshott RN, Padfield PL, Douglas NJ. Ambulatory blood pressure on and off continuous positive airway pressure therapy for the sleep apnoea/liypopnoea syndrome: effects in « non-dippers ». Sleep 1996, 19: 378-381.
52. Moller DS, Lind P, Strunge B, Pedersen E. Abnormal vasoactive hormones and 24hr blood pressure in obstructive sleep apnoea. Am J Hypertens 2003, 16: 274-280.
53. Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000, 284: 3015-3021.
54. Narkiewicz K, Montano N, Cogliatti C, van de Borne PJ, Dyken ME, Somers VK. Altered cardiovascular variability in obstructive sleep apnea. Circulation 1998, 98: 1071-1077.
55. Narkiewicz K, Kato M, Phillips BG, Pesek CA, Davison DE, Somers VK. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnoea. Circulation 1999, 100: 2332-2335.
56. Roche F, Court-Fortune I, Pichot V et al. Reduced cardiac sympathetic autonomic tone after long term nasal continuous positive airway pressure in obstructive sleep apnoea syndrome. Clin Physiol 1999, 19: 127-134.
57. Veale D, Pepin JL, Wuyam B, Levy PA. Abnormal autonomic stress responses in obstructive sleep apnoea are reversed by nasal continuous positive airway pressure. Eur Respir J 1996, 9: 2122-2126.
58. Belozeroff V, Berry R, Sassoon CS, Khoo MC. Effects of CPAP therapy on cardiovascular variability in obstructive sleep apnoea: a closed loop analysis. Am J Physiol Heart Circ Physiol 2002, 282: H110-H121.
59. Bonsignore MR, Parati G, Insalaco G et al. Continuous positive airway pressure treatment improves baroreflex control of heart rate during sleep in severe obstructive sleep apnoea syndrome. Am J Respir Crit Care Med 2002, 166: 279-286.